ArticleFrontiers in pharmacology2024

Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study.

Rubén Martín-Escolano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.